Ruth O'Regan

Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation.

Frank Emmrich, Jan-Michael Heinrich, F. Emmrich, 2006, Nano letters.

The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy

R. O'Regan, Ruth O'Regan, Tina Constantine, 2012, Chemotherapy research and practice.

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

Larry Norton, Donald A Berry, Edith A Perez, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer

Limin Peng, Kevin C Ward, A. Sahin, 2016, Breast Cancer Research and Treatment.